Prevention of Nephrotoxin-Induced Acute Kidney Injury Using Cilastatin
NCT06886464
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
698
Enrollment
OTHER
Sponsor class
Conditions
Acute Kidney Injury
Interventions
DRUG:
Cilastatin Sodium
DRUG:
Placebo-Saline
Sponsor
Matthew James
Collaborators
[object Object]
[object Object]